healthneutral
A New Light on Fatty Liver Disease
Friday, November 22, 2024
Out of these probes, COB2 was picked for further study because it had the best ability to resists unwanted interference. Tests showed that COB2 could pinpoint both fat droplets and the ER at the same time, and it could show changes in these organelles under different health conditions. Plus, it could tell the difference between a normal liver and a fatty liver at the tissue level.
These findings are a step forward in developing new probes that can target two things at once. They could help in the early diagnosis of NAFLD, which is great news. Keep in mind, though, that more research is needed before these probes can be used in real-life situations.
It's fascinating how these tiny probes can help us understand a big health issue in a whole new way.
Actions
flag content